Can-Fite BioPharma Ltd. - American Depositary Receipt logo

Can-Fite BioPharma Ltd. - American Depositary Receipt (CANF)

Market Open
11 Sep, 14:00
AMEX AMEX
$
2. 16
+0
+0.0926%
$
2.92M Market Cap
- P/E Ratio
0.68% Div Yield
10,914 Volume
- Eps
$ 2.16
Previous Close
Investors:
Add Transaction
Day Range
2.16 2.24
Year Range
2.16 13.4
Want to track CANF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Can-Fite BioPharma Ltd. - American Depositary Receipt (CANF) Statistics

Valuation metrics

Market Cap 2.92M
Enterprise value -97.47K
Trailing P/E (ttm) -0.54
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 13.23
Price/Book (mrq) 0.48
Enterprise Value/Revenue -0.24
Enterprise Value/EBITDA 0.01

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 179.45K
Average volume (90 days) 7.71M

Price summary

52-Week low 2.16
52-Week high 13.4
Beta -
50-Day moving average 3.04
200-Day moving average 3.49

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 5 Jan 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -24.27%
Operating margin -24.57%

Operational effectiveness

Return on assets -1.03%
Return on equity -2.01%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.38
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -9.12
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 7.93
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.46%
Book value per share (mrq) 5.19

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -